IP Library Granted Patent US 7,452,565
Granted Patent B2
US 7,452,565 · App. 10/868,451 · Granted Nov 18, 2008

Immobilization of bead-displayed ligands on substrate surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,452,565
App. No.
10/868,451
Granted
Nov 18, 2008
Kind
B2
Abstract

Disclosed are two different approaches for immobilization of beads on a substrate, one of which involves forming a bead-nanoparticle composite by cross-linking of the bead mixture with nanoparticles. The other method involves surface modification of the substrate, using multi-layered polyelectrolytes. With either method, the beads are immobilized on the substrate in a manner suitable for viewing, as when the beads are used in assays and need to be analyzed following the assay. Different designs of depressions are also disclosed, some of which are suitable for holding beads in place without any deposition of nanoparticles or polyelectrolytes.

Claims (19)

1. A method of affixing an array of microparticles in a series of recesses in a substrate surface, comprising:

placing microparticles in said series of recesses in a manner such that one microparticle resides in any one recess;

placing a nanoparticle suspension on the substrate surface over said series of recesses having microparticles therein;

incubating the nanoparticle suspension with the microparticle containing substrate whereby numerous nanoparticles get deposited and wedged between the microparticle and the walls of the recess in which it resides.

2. The method of claim 1 wherein the incubation period is chosen such that at the end of the incubation evaporation does not substantially remove liquid from the substrate surface so as to create a nanoparticle coating.

3. The method of claim 1 wherein the substrate surface is further coated to inhibit non-specific binding of oligonucleotide compounds which contact with the substrate.

4. The method of claim 3 wherein the coating is a polymer.

5. The method of claim 4 wherein the polymer is PEG 20,000, applied by first dissolving it in 10 mM Tris with 3% (v/v) glycerol.

6. The method of claim 1 wherein the microparticle is housed in a depression.

7. The method of claim 6 wherein the recesses depression is a cylindrical hole of slightly larger inner diameter than the outer diameter of the microparticle, or is a hole with inwardly tapered sides and the inner diameter of the opening is large enough such that the microparticle can be housed within the depression.

8. The method of claim 1 wherein the microparticle consists of a polymer.

9. The method of claim 8 wherein the polymer is latex.

10. The method of claim 1 wherein the microparticle is functionalized with a protein.

11. The method of claim 10 wherein the microparticle is functionalized with an oligonucleotide.

12. The method of claim 10 wherein the protein is neutravidin.

13. The method of claim 1 wherein the nanoparticle consists of silica, which is suspended in an aqueous glycerol solution.

14. The method of claim 1 wherein the substrate has a plurality of depressions, and each accommodates one microparticle.

15. The method of claim 1 wherein most of the nanoparticles deposited in any particular recess are deposited in the gap between the curved surface of the microparticle nearer to the substrate surface and the opposing portion of such recess wall.

16. The method of claim 1 wherein following incubation, the excess nanoparticle suspension is removed and the surface of the substrate cleaned by thorough scrubbing and washing.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2011
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026778/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2008
From: BANERJEE, SUKANTA
To: BIOARRAY SOLUTIONS LTD.
Reel/Frame 020498/0860 →